Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Authors' reply

A. Smolinska, F. J. van Schooten*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)372-372
Number of pages1
JournalAlimentary Pharmacology & Therapeutics
Volume46
Issue number3
DOIs
Publication statusPublished - Aug 2017

Cite this

@article{b6f87617d79240d28cef64e2200b6957,
title = "Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Authors' reply",
author = "A. Smolinska and {van Schooten}, {F. J.}",
year = "2017",
month = "8",
doi = "10.1111/apt.14163",
language = "English",
volume = "46",
pages = "372--372",
journal = "Alimentary Pharmacology & Therapeutics",
issn = "0269-2813",
publisher = "Wiley",
number = "3",

}

Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Authors' reply. / Smolinska, A.; van Schooten, F. J.

In: Alimentary Pharmacology & Therapeutics, Vol. 46, No. 3, 08.2017, p. 372-372.

Research output: Contribution to journalEditorialAcademicpeer-review

TY - JOUR

T1 - Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Authors' reply

AU - Smolinska, A.

AU - van Schooten, F. J.

PY - 2017/8

Y1 - 2017/8

U2 - 10.1111/apt.14163

DO - 10.1111/apt.14163

M3 - Editorial

VL - 46

SP - 372

EP - 372

JO - Alimentary Pharmacology & Therapeutics

JF - Alimentary Pharmacology & Therapeutics

SN - 0269-2813

IS - 3

ER -